Opinion|Videos|August 19, 2024
Patient Access Advocacy for BTK Inhibitors
A panel of specialists discuss patient access advocacy for BTK inhibitors.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How do changes in patient out-of-pocket costs under the IRA influence treatment and sequencing decisions?
- What strategies can healthcare providers use to advocate for patient access to BTK inhibitors?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
COVID Is Back in the Bay Area: Is It the XFG "Stratus" Variant?
2
Zanubrutinib Outlasting Acalabrutinib in CLL
3
Atlanta Panel Confronts Bottlenecks in Alzheimer Disease Diagnosis and Care
4
FDA Clears Lerodalcibep-Liga Autoinjector, Widens LDL-C Indication
5